Food and Drug Administration (FDA) Director General Dr. Eric Domingo on Monday confirmed his resignation as chief of the agency.
FDA deputy director general Oscar Gutierrez will be assigned as officer-in-charge of the regulator, the Department of Health (DOH) said.
In a report, Domingo told GMA News Online that his resignation is effective January 3.
When asked for the reason for his resignation, Domingo said he does not have any specific reason.
“Wala naman dahilan (There’s no reason),” he said. “I think I did my part to help during the pandemic. I’m happy with that but now it is time to move on to other things.”
Domingo was named as officer-in-charge of the regulatory office in May 2019, the DOH said. He was named as FDA director-general in May 2020.
“Yes, effective today. I believe I did my part to help during the pandemic. The FDA is now stronger, more efficient and systems are in place.
It’s time for me to move on to other things,” he told ABS-CBN News in a separate interview.
It was under Domingo’s helm that the FDA granted the emergency use authorization (EUA) of nine COVID-19 vaccines and two drugs used in coronavirus treatment.